论文部分内容阅读
上海医药行业原有衡山等四家集体企业,在激烈的市场竞争中,三家早已销声匿迹,唯有衡山药厂至今还依然拥有占地200亩的厂区,巍然立于沪闵路旁。2000年,在消化了市场药品降价的不利因素后,衡山厂销售额达1.17亿元,比1999年同比增长9.42%;产值达2.2亿元,比1999年同比增长21.69%;利润达509万元,比1999年同比增长9.23%;人均创利达2.24万元,比99年同比增长9.27%;劳动生产率人均
In the fierce market competition of the four original collective enterprises such as Hengshan in the Shanghai pharmaceutical industry, the three have long disappeared. Only the Hengshan Pharmaceutical Factory still has a plant area of 200 acres and stands on the side of the Humin Road. In 2000, after digesting the unfavorable factors of market price cuts for pharmaceuticals, the sales of Hengshan Plant reached 117 million yuan, an increase of 9.42% compared to the same period in 1999; the output value reached 220 million yuan, an increase of 21.69% from the same period of 1999; and the profit reached 5.09 million yuan. , an increase of 9.23% over the same period in 1999; the per capita profit reached 22,400 yuan, an increase of 9.27% over the same period in 1999; labor productivity per capita